A Survey of the Real-world Patient-reported Experience of Follow-up Practices Following Radical Surgery or Radiotherapy for Muscle-invasive Bladder Cancer (MIBC)

被引：0
|
作者：
Hack, J. [1 ]
Crabb, S. [1 ]
Costin, M. [2 ]
Kelly, P. [3 ]
Makaroff, L. [2 ]
Douglas, J. [1 ]
机构：
[1] Univ Hosp Southampton, Southampton, England
[2] Fight Bladder Canc, Chinnor, England
[3] Act Bladder Canc UK, Tetbury, England
来源：
CLINICAL ONCOLOGY | 2023年 / 35卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E238 / E238
页数：1
相关论文
共 50 条
  • [41] Biomarker analysis and updated clinical follow-up from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in patients with muscle-invasive bladder cancer (MIBC) undergoing cystectomy.
    Gupta, Shilpa
    Gibb, Ewan
    Sonpavde, Guru P.
    Gupta, Sumati
    Maughan, Benjamin L.
    Agarwal, Neeraj
    McGregor, Bradley Alexander
    Weight, Christopher
    Wei, Xiao X.
    Einstein, David Johnson
    Dechet, Christopher B.
    Preston, Mark A.
    Mossanen, Matthew
    Thygarajan, Bharat
    Eckstein, Markus
    Diaz-Montero, C. Marcela
    Murugan, Paari J.
    Black, Peter C.
    Konety, Badrinath R.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [42] EXTERNAL VALIDATION OF A DECISION-SUPPORT TOOL FOR BORDERLINE OPERABLE MUSCLE-INVASIVE BLADDER CANCER (MIBC) PATIENTS CHOOSING BETWEEN RADICAL CYSTECTOMY AND CHEMO-RADIOTHERAPY
    Baumann, Brian
    Hwang, Wei-Ting
    Srinivasan, Sharadha
    Mamtani, Ronac
    Vaughn, David
    Xia, Leilei
    Malkowicz, S. Bruce
    Guzzo, Thomas
    Christodouleas, John
    JOURNAL OF UROLOGY, 2018, 199 (04): : E311 - E312
  • [43] Bladder-sparing treatment using tislelizumab combined with gemcitabine/cisplatin in selected patients with muscle-invasive bladder cancer: a real-world study
    Luo, Cheng
    Luo, Shuhang
    Wusimanjiang, Wumier
    Wang, Zongren
    Liu, Ping
    Wang, Bin
    Yuan, Dan
    Lin, Hao
    Xu, Abai
    Deng, Nan
    Wu, Kaihui
    Zhu, Xuejin
    Xu, Peng
    Chen, Junxing
    Huang, Bin
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (07): : 1759 - 1767
  • [44] Disitamab Vedotin Alone or in Combination With Immune Checkpoint Inhibitors in Bladder-Sparing Treatment of Muscle-Invasive Bladder Cancer: A Real-World Study
    Wang, Anbang
    Chen, Ming
    Li, Duocai
    Shi, Jiazi
    Tang, Wenbin
    Zhang, Zongqin
    Ren, Shancheng
    CLINICAL GENITOURINARY CANCER, 2024, 22 (03)
  • [45] Cancer follow-up supported by patient-reported outcomes in patients undergoing intended curative complex surgery for advanced cancer
    Ravn, Sissel
    Thaysen, Henriette Vind
    Verwaal, Victor Jilbert
    Seibaek, Lene
    Iversen, Lene Hjerrild
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2021, 5 (01)
  • [46] Cancer follow-up supported by patient-reported outcomes in patients undergoing intended curative complex surgery for advanced cancer
    Sissel Ravn
    Henriette Vind Thaysen
    Victor Jilbert Verwaal
    Lene Seibæk
    Lene Hjerrild Iversen
    Journal of Patient-Reported Outcomes, 5
  • [47] Risk factors for patient-reported errors during cancer follow-up: Results from a national survey in Denmark
    Christiansen, Anne Hjollund
    Lipczak, Henriette
    Knudsen, Janne Lehmann
    Kejs, Anne Mette Tranberg
    CANCER EPIDEMIOLOGY, 2017, 49 : 38 - 45
  • [48] Bladder Preservation Strategy Based on Combined Therapy in Patients with Muscle-Invasive Bladder Cancer: Management and Results at Long-Term Follow-Up
    Villavicencio, Humberto
    Rodriguez Faba, Oscar
    Palou, Joan
    Gausa, Luis
    Algaba, Ferran
    Marcuello, Eugenio
    UROLOGIA INTERNATIONALIS, 2010, 85 (03) : 281 - 286
  • [49] Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: A multi-center real-world retrospective study
    Hu, Jiao
    Chen, Jinbo
    Ou, Zhenyu
    Chen, Haige
    Liu, Zheng
    Chen, Minfeng
    Zhang, Ruiyun
    Yu, Anze
    Cao, Rui
    Zhang, Enchong
    Guo, Xi
    Peng, Bo
    Deng, Dingshan
    Cheng, Chunliang
    Liu, Jinhui
    Li, Huihuang
    Zou, Yihua
    Deng, Ruoping
    Qin, Gang
    Li, Wenze
    Wang, Lue
    Chen, Tao
    Pei, Xiaming
    Gong, Guanghui
    Tang, Jiansheng
    Othmane, Belaydi
    Cai, Zhiyong
    Zhang, Chunyu
    Liu, Zhi
    Zu, Xiongbing
    CELL REPORTS MEDICINE, 2022, 3 (11)
  • [50] Paving the Road to the Future of Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-year Follow-up of BC2001
    Solanki, Abhishek A.
    Kates, Max R.
    Tran, Phuoc T.
    EUROPEAN UROLOGY, 2022, 82 (03) : 280 - 282
12345